Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gathering information about cognitive function over time in postmenopausal women
with breast cancer may help doctors learn about the long-term effects of aromatase inhibitor
therapy and plan the best treatment.
PURPOSE: This clinical trial is studying cognitive function in older postmenopausal women
with stage I, stage II, or stage III breast cancer receiving hormone therapy and in healthy
volunteers.